health canada approval zepbound tirzepatide obesity canada date approves weight-loss drug for sleep apnea in patients with Health Canada Authorizes Zepbound as

And if youre struggling with your weight, fiber might be the secret to finally seeing the scale heading in a downward trend

J rgensen, Process for Purifying Insulin, US Patent No

However, like other highly effective glucose-lowering medications, rapid improvements in blood sugar control can temporarily worsen existing retinopathy in susceptible individuals

In general, semaglutide (Wegovy ) and tirzepatide (Zepbound ) are FDA-approved for weight loss in people with: A BMI of 30 or higher , or A BMI of 27 or higher with at least one weight-related condition, like type 2 diabetes or high blood pressure Each medication also has additional FDA-approved uses beyond weight loss: Wegovy is also approved to reduce the risk of major cardiovascular events like heart attack and stroke in adults with cardiovascular disease